Giulia Serra

Papers

Total Citations

H-Index

About

Giulia Serra is a clinical researcher whose work focuses on the frontiers of psychopharmacology and the treatment of complex, treatment-resistant psychiatric conditions. Her primary research areas include major depressive disorder, dissociative symptoms, and novel glutamatergic agents. Serra’s most notable contribution is her pioneering investigation into REL-1017 (Esmethadone), an N-methyl-D-aspartate (NMDA) receptor antagonist, for rapidly reducing dissociative symptoms in adults with major depressive disorder unresponsive to standard antidepressants. This work, published in 2022, addresses a critical gap in psychiatric care, as dissociative disorders are highly prevalent yet severely underdiagnosed—affecting up to 29% of outpatient psychiatric populations, with only 5% previously identified. By demonstrating that REL-1017 may offer rapid relief for these debilitating symptoms, Serra’s research opens new therapeutic avenues for patients who have exhausted conventional treatments. Her contributions are particularly impactful given the high comorbidity of dissociative states with other psychiatric disorders. With 6 citations to this key paper, Serra’s findings are gaining traction, positioning her as an emerging voice in the development of fast-acting, mechanism-based interventions for some of psychiatry’s most challenging presentations.